147 related articles for article (PubMed ID: 37605807)
1. AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines.
Masumoto N; Kato S; Aichi M; Hasegawa S; Sahara K; Suyama K; Sano A; Miyazaki T; Okudela K; Kaneko T; Takahashi T
Thorac Cancer; 2023 Oct; 14(29):2897-2908. PubMed ID: 37605807
[TBL] [Abstract][Full Text] [Related]
2. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
Song P; Sekhon HS; Lu A; Arredondo J; Sauer D; Gravett C; Mark GP; Grando SA; Spindel ER
Cancer Res; 2007 Apr; 67(8):3936-44. PubMed ID: 17440109
[TBL] [Abstract][Full Text] [Related]
3. Perampanel Inhibits Neuroblastoma Cell Proliferation Through Down-regulation of AKT and ERK Pathways.
Nozawa A; Ozeki M; Matsuoka M; Nakama M; Yasue S; Endo S; Kawamoto N; Ohnishi H; Fukao T
Anticancer Res; 2019 Jul; 39(7):3595-3599. PubMed ID: 31262884
[TBL] [Abstract][Full Text] [Related]
4. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.
Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T
Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131
[TBL] [Abstract][Full Text] [Related]
5. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells.
Jull BA; Plummer HK; Schuller HM
J Cancer Res Clin Oncol; 2001 Dec; 127(12):707-17. PubMed ID: 11768610
[TBL] [Abstract][Full Text] [Related]
7. Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer.
Kimura S; Harada T; Ijichi K; Tanaka K; Liu R; Shibahara D; Kawano Y; Otsubo K; Yoneshima Y; Iwama E; Nakanishi Y; Okamoto I
Lung Cancer; 2018 Jun; 120():98-107. PubMed ID: 29748024
[TBL] [Abstract][Full Text] [Related]
8. The neurotoxin 1-methyl-4-phenylpyridinium: a selective cytostatic agent in small-cell lung cancer cell lines with neuroendocrine properties.
Marini AM; Fridman R; Kanemoto T; Martin GR; Guo Y; Passaniti A
J Natl Cancer Inst; 1992 Oct; 84(20):1582-7. PubMed ID: 1328660
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional modulation of calcium-permeable AMPA receptor subunits in glioblastoma by MEK-ERK1/2 inhibitors and their role in invasion.
Ramaswamy P; Dalavaikodihalli Nanjaiah N; Prasad C; Goswami K
Cell Biol Int; 2020 Mar; 44(3):830-837. PubMed ID: 31814223
[TBL] [Abstract][Full Text] [Related]
10. Suppression of growth of H-69 small cell lung carcinoma by antagonists of growth hormone releasing hormone and bombesin is associated with an inhibition of protein kinase C signaling.
Kanashiro CA; Schally AV; Zarandi M; Hammann BD; Varga JL
Int J Cancer; 2004 Nov; 112(4):570-6. PubMed ID: 15382037
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis.
Khan P; Siddiqui JA; Kshirsagar PG; Venkata RC; Maurya SK; Mirzapoiazova T; Perumal N; Chaudhary S; Kanchan RK; Fatima M; Khan MA; Rehman AU; Lakshmanan I; Mahapatra S; Talmon GA; Kulkarni P; Ganti AK; Jain M; Salgia R; Batra SK; Nasser MW
Mol Cancer; 2023 Jan; 22(1):1. PubMed ID: 36597126
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
[TBL] [Abstract][Full Text] [Related]
13. Critical role of G(alpha)12 and G(alpha)13 for human small cell lung cancer cell proliferation in vitro and tumor growth in vivo.
Grzelinski M; Pinkenburg O; Büch T; Gold M; Stohr S; Kalwa H; Gudermann T; Aigner A
Clin Cancer Res; 2010 Mar; 16(5):1402-15. PubMed ID: 20160064
[TBL] [Abstract][Full Text] [Related]
14. Src/CK2/PTEN-Mediated GluN2B and CREB Dephosphorylations Regulate the Responsiveness to AMPA Receptor Antagonists in Chronic Epilepsy Rats.
Kim JE; Lee DS; Park H; Kang TC
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348808
[TBL] [Abstract][Full Text] [Related]
15. Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Bepler G; Jaques G; Koehler A; Gropp C; Havemann K
J Cancer Res Clin Oncol; 1987; 113(3):253-9. PubMed ID: 2438285
[TBL] [Abstract][Full Text] [Related]
16. Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.
Plummer HK; Dhar MS; Cekanova M; Schuller HM
BMC Cancer; 2005 Aug; 5():104. PubMed ID: 16109170
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of experimental small-cell and non-small-cell lung cancers by novel antagonists of growth hormone-releasing hormone.
Wang H; Zhang X; Vidaurre I; Cai R; Sha W; Schally AV
Int J Cancer; 2018 Jun; 142(11):2394-2404. PubMed ID: 29435973
[TBL] [Abstract][Full Text] [Related]
18. Hedgehog signaling in small-cell lung cancer: frequent in vivo but a rare event in vitro.
Vestergaard J; Pedersen MW; Pedersen N; Ensinger C; Tümer Z; Tommerup N; Poulsen HS; Larsen LA
Lung Cancer; 2006 Jun; 52(3):281-90. PubMed ID: 16616798
[TBL] [Abstract][Full Text] [Related]
19. microRNA-195 Promotes Small Cell Lung Cancer Cell Apoptosis via Inhibiting Rap2C Protein-Dependent MAPK Signal Transduction.
Tong J; Lu J; Yin Y; Wang Y; Zhang K
Technol Cancer Res Treat; 2020; 19():1533033820977546. PubMed ID: 33302819
[TBL] [Abstract][Full Text] [Related]
20. Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects.
Elahi AH; Morales CS; Xu XL; Eliades A; Patsalis PC; Abramson DH; Jhanwar SC
Adv Biol Regul; 2023 May; 88():100964. PubMed ID: 37004354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
